Results 51 to 60 of about 9,727 (224)

A retrospective comparison of cyclophosphamide plus antithymocyte globulin with cyclophosphamide plus busulfan as the conditioning regimen for severe aplastic anemia [PDF]

open access: yes, 2009
Allogeneic hematopoietic stem cell transplantation (AHSCT) is the treatment of choice for young patients with severe aplastic anemia (SAA). The association of antithymocyte globulin (ATG) and cyclophosphamide (CY) is the most frequently used conditioning
Chauffaille, Maria de Lourdes Lopes Ferrari   +5 more
core   +2 more sources

Emerging respiratory viral infections: MERS-CoV and influenza [PDF]

open access: yes, 2014
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Tawfiq, Jaffar A., Memish, Ziad A.
core   +1 more source

Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients : a new classification from the European society for blood and marrow transplantation [PDF]

open access: yes, 2017
The advances in hematopoietic cell transplantation (HCT) over the last decade have led to a transplant-related mortality below 15%. Hepatic sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) is a life-threatening complication of HCT that ...
A Akil   +122 more
core   +3 more sources

Familial Pulmonary Capillary Hemangiomatosis Early in Life [PDF]

open access: yes, 2013
Background: Pulmonary capillary hemangiomatosis (PCH) is a rare disease, especially in infancy. Four infants have been reported up to the age of 12 months. So far, no familial patients are observed at this age.
Hebestreit, Helge   +4 more
core   +1 more source

Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension

open access: yesJournal of the Formosan Medical Association, 2020
Background/purpose: Pulmonary veno-occlusive disease (PVOD) is a rare but fatal cause of pulmonary hypertension reported to be linked to mutations of eukaryotic initiation factor 2 alpha kinase 4 (EIF2AK4), also known as general control nonderepressible ...
Ying-Ju Lai   +3 more
doaj   +1 more source

Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus [PDF]

open access: yes, 2016
Although there are high survival rates for children with acute lymphoblastic leukaemia, their outcome is often counterbalanced by the burden of toxic effects.
Attarbaschi, Andishe   +20 more
core   +2 more sources

Co-existence of vocal cord dysfunction with pulmonary conditions other than asthma: A case series

open access: yesRespiratory Medicine Case Reports, 2018
Background: Vocal cord dysfunction (VCD) is defined as inappropriate movement of the vocal cords resulting in functional airway obstruction and symptoms including cough, wheezing, and dyspnea.
Merritt L. Fajt   +3 more
doaj   +1 more source

Acute pulmonary hypertension caused by tumor embolism: a report of two cases. [PDF]

open access: yes, 2015
Acute pulmonary hypertension leading to right ventricular failure and circulatory collapse is usually caused by thromboembolic obstruction of the pulmonary circulation.
Liaudet, L.   +4 more
core   +1 more source

Clinical features of canine pulmonary veno‐occlusive disease and pulmonary capillary hemangiomatosis

open access: yesJournal of Veterinary Internal Medicine, 2019
Background Histologic features of pulmonary veno‐occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) have been described in dogs but without a thorough clinical description.
Carol R. Reinero   +5 more
doaj   +1 more source

Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension [PDF]

open access: yes, 2017
Pulmonary arterial hypertension (PAH) describes a group of conditions with a common hemodynamic phenotype of increased pulmonary artery pressure, driven by progressive remodeling of small pulmonary arteries, leading to right heart failure and death ...
Lawrie, A., Thompson, A.A.R.
core   +1 more source

Home - About - Disclaimer - Privacy